Medication use and disease management of type 2 diabetic flemish patients

被引:9
作者
Els Mehuys
Leen De Bolle
Luc Van Bortel
Lieven Annemans
Inge Van Tongelen
Jean-Paul Remon
Mimi Giri
机构
[1] Ghent University,Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences
[2] Ghent University,Heymans Institute of Pharmacology, Faculty of Medicine and Health Sciences
[3] Ghent University,Department of Public Health, Faculty of Medicine and Health Sciences
[4] Ghent University Hospital,Department of Endocrinology and Diabetology
来源
Pharmacy World & Science | 2008年 / 30卷
关键词
Type 2 diabetes; Pharmacotherapy; Self-management; Community pharmacists; Belgium;
D O I
暂无
中图分类号
学科分类号
摘要
Objective The aim of this study was (International Diabetes Federation. Diabetes Atlas Second Edition Executive Summary. Brussels: International Diabetes Federation; 2003) to describe the current status of medication use and disease management of type 2 diabetic patients in Flanders (Belgium), (World Health Organization. Prevention of diabetes mellitus. Technical report series no. 844. Geneva: World Health Organization; 1994) to identify the aspects of type 2 diabetes care a community pharmacist could provide additional educational services for, and (American Diabetes Association. Diabetes Care 2006;29:S4–42) to propose these services as a pharmacist intervention. Method We recruited 338 patients in 77 community pharmacies in Flanders (Belgium). Each patient completed a questionnaire collecting personal data, information on duration of diabetes, medication, diabetes symptoms and self-management. At inclusion, patients measured their fasting plasma glucose (FPG) on three consecutive days. Prescription drugs (antidiabetic and other) purchased by each patient during the 12 months prior to inclusion in the study were reviewed from anonymized computerized pharmacy records. Main outcome measures Degree of self-management, glycaemic control and medication use. Results The mean FPG of the sample was 150.7 ± 43.0 mg/dl. Controlled glycaemia (FPG between 90 and 130 mg/dl (5.0–7.2 mmol/l)) was achieved in only 34.9% of the patients. Mainstay of hypoglycemic treatment consisted of metformin monotherapy (29.6%) and metformin combined with sulfonylurea (29.0%). Regarding co-medication, 76.9% of the patients used antihypertensive drugs whereas only 33.1% and 39.9% were on aspirin and statin therapy, respectively. ADA recommendations for annual eye and foot examination were not followed in 38.8% (eye) and 39.2% (feet) of the patients. Conclusion The current management of type 2 diabetic Flemish patients falls short of recommended treatment goals. Community pharmacists may play a role in enhancing the awareness of glycaemic control and in stimulating selfmanagement in diabetic patients by motivating patients towards correct medication use, better medication adherence, healthy lifestyle and smoking cessation.
引用
收藏
页码:51 / 56
页数:5
相关论文
共 84 条
[1]  
Hepler CD(2006)Standards of medical care in diabetes Diabetes Care 29 S4-42
[2]  
Strand LM(1990)Opportunities and responsibilities in pharmaceutical care Am J Hosp Pharm 47 533-43
[3]  
Cranor CW(2003)The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program J Am Pharm Assoc 43 173-84
[4]  
Bunting BA(1996)Evaluation of a pharmaceutical care model on diabetes management Ann Pharmacother 30 238-43
[5]  
Christensen DB(1998)Management of patients with type 2 diabetes by pharmacists in primary care clinics Ann Pharmacother 32 636-41
[6]  
Jaber LA(2005)Impact on medication use and adherence of Australian pharmacists’ diabetes care services J Am Pharm Assoc 45 33-40
[7]  
Halapy H(2004)Implementation and evaluation of Australian pharmacists’ diabetes care services J Am Pharm Assoc 44 455-66
[8]  
Fernet M(2002)A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic Int J Pharm Pract 10 85-9
[9]  
Tummalapalli S(1999)Improving outcomes of community-dwelling older patients with diabetes through pharmacist counselling Am J Health Syst Pharm 56 1535-9
[10]  
Diwakaran H(2004)Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 291 335-42